Latest Contract Renewals News

Page 1 of 14
The week was split between big earnings reactions and small-cap rocks-and-rigs rallies. Pro Medicus sank despite record numbers, while a handful of explorers jumped on fresh discoveries and policy wins.
Logan Eniac
Logan Eniac
14 Feb 2026
Healthcare stocks split into two stories this week: big names sold off hard, while a few small caps ran on clear news. The biggest moves came from a sharp fall in Pro Medicus and Cochlear, while Noxopharm jumped after a top-tier journal publication.
Logan Eniac
Logan Eniac
14 Feb 2026
Cochlear Limited reported a modest 1% rise in HY26 sales revenue to $1.176 billion, but underlying net profit fell 9% amid slower-than-expected contract renewals for its new Nucleus Nexa implant system. The company anticipates a stronger second half and maintains full-year guidance at the lower end of its forecast.
Ada Torres
Ada Torres
13 Feb 2026
Cochlear Limited reported a modest 1% rise in sales but a 9% fall in underlying net profit for the half year ended December 2025, as the rollout of its innovative Nucleus Nexa System faced longer-than-expected regulatory and contract hurdles. The company anticipates a robust second half driven by broader product availability and service growth.
Ada Torres
Ada Torres
13 Feb 2026
Cochlear Limited posted a modest 1% increase in sales revenue for the half year ending December 2025, while underlying net profit fell 9%, impacted by cloud computing costs and a slower-than-expected Nexa System rollout. The company maintains its dividend and outlines cautious FY26 guidance.
Ada Torres
Ada Torres
13 Feb 2026
Pro Medicus has reported its strongest half-year performance yet, with revenue and profits surging alongside a wave of new multi-million dollar contracts and strategic AI investments. The healthcare IT leader is expanding its global footprint and cloud capabilities, setting the stage for sustained growth.
Ada Torres
Ada Torres
12 Feb 2026
FirstWave has unveiled a strategic shift towards AI-powered compliance management, backed by strong user growth for its Open-AudIT platform and significant cost savings from restructuring.
Sophie Babbage
Sophie Babbage
6 Feb 2026
A handful of healthcare names did the heavy lifting this week, driven by FDA wins, guideline upgrades, and big shifts in sales and cashflow. The flip side: several clinical-stage stocks fell hard as investors stayed picky about near-term proof and funding.
Logan Eniac
Logan Eniac
31 Jan 2026
A handful of small caps ripped higher, but plenty still slipped even after good news. This week’s biggest moves came from a platform partnership win, a reinstated stock, and a cash settlement that removed a long-running dispute.
Logan Eniac
Logan Eniac
31 Jan 2026
FirstWave Cloud Technology has completed a $2.66 million capital raise alongside operational restructuring and a strategic shift to AI-powered compliance management, positioning itself for growth with renewed key contracts and improved cash flow.
Sophie Babbage
Sophie Babbage
30 Jan 2026
FirstWave Cloud Technology Limited has completed a $2.66 million capital raise alongside an operational restructure, setting the stage for its strategic pivot to AI-powered compliance management. The company expects a cash-flow positive quarter ahead, supported by key contract renewals and anticipated R&D rebates.
Sophie Babbage
Sophie Babbage
30 Jan 2026
IMEXHS Limited has reported a strong finish to FY25, delivering revenue and underlying EBITDA at the top end of its guidance, driven by robust software growth and expanding recurring revenue.
Ada Torres
Ada Torres
30 Jan 2026